Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis. [electronic resource]
- European journal of pharmacology Jun 2019
- 142-150 p. digital
Publication Type: Journal Article
1879-0712
10.1016/j.ejphar.2019.03.013 doi
Animals Apoptosis--drug effects Atrasentan--pharmacology Autophagy--drug effects Dose-Response Relationship, Drug Forkhead Box Protein O1--genetics Gene Expression Regulation--drug effects Glucose--pharmacology HeLa Cells Humans Male Mice Mice, Inbred C57BL MicroRNAs--genetics Podocytes--drug effects Signal Transduction--drug effects